Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hunan Fangsheng Pharmaceutical Co Ltd (603998) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9376
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise’ products include tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, sprays, lotions, extracted TCM lotions, small volume injections and bulk pharmaceutical chemicals. It also provides cephalosporins, metacycline hydrochloride capsules, cefminox sodium injections, cefprozil tablets, dispersible tablets, heat clearing and detoxifying tablets. Fangsheng Pharma offers vitamin B granules, chewable tablets, anti-infectives and calcium tablets, among others. The enterprise provides services such as manufacturing, research and development, research and development framework and planning, science and technology. Fangsheng Pharma is headquartered in Changsha, China.

Hunan Fangsheng Pharmaceutical Co Ltd (603998) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hunan Fangsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Hunan Fangsheng Pharma Forms Joint Venture with Gene Technology Company 11
Equity Offering 12
Hunan Fangsheng Pharma Withdraws Plan to Raise Funds in Private Placement of shares 12
Acquisition 13
Hunan Fangsheng Pharma to Invest USD3 Million in Lipomedics 13
Hunan Fangsheng Pharma Plans to Sell its 57.5% Stake in Pharma Subsidiary for USD1.6 Million 14
Hunan Fangsheng Pharmaceutical Co Ltd – Key Competitors 15
Hunan Fangsheng Pharmaceutical Co Ltd – Key Employees 16
Hunan Fangsheng Pharmaceutical Co Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hunan Fangsheng Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Hunan Fangsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hunan Fangsheng Pharma Forms Joint Venture with Gene Technology Company 11
Hunan Fangsheng Pharma Withdraws Plan to Raise Funds in Private Placement of shares 12
Hunan Fangsheng Pharma to Invest USD3 Million in Lipomedics 13
Hunan Fangsheng Pharma Plans to Sell its 57.5% Stake in Pharma Subsidiary for USD1.6 Million 14
Hunan Fangsheng Pharmaceutical Co Ltd, Key Competitors 15
Hunan Fangsheng Pharmaceutical Co Ltd, Key Employees 16

List of Figures
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hunan Fangsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Protagen AG:医療機器:M&Aディール及び事業提携情報
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provi …
  • GridEdge Networks Inc:企業の戦略的SWOT分析
    GridEdge Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company offers banking, insurance companies, public institutions, healthcare, telecommunication, utilities, ERP solutions, IT infrastructure and others. Its IT infrastructure solutions include …
  • RBS Wealth Management:企業の戦略・SWOT・財務情報
    RBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ADES International Holding Plc (ADES):企業の財務・戦略的SWOT分析
    ADES International Holding Plc (ADES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Laredo Petroleum Inc (LPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Laredo Petroleum Inc (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company h …
  • Keysight Technologies Inc:戦略・SWOT・企業財務分析
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Shipping Corporation of India Ltd (SCI):企業の財務・戦略的SWOT分析
    The Shipping Corporation of India Ltd (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務分析
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Johnson Outdoors Inc (JOUT):企業の財務・戦略的SWOT分析
    Johnson Outdoors Inc (JOUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bruel & Kjaer Sound & Vibration Measurement AS:企業の戦略・SWOT・財務情報
    Bruel & Kjaer Sound & Vibration Measurement AS - Strategy, SWOT and Corporate Finance Report Summary Bruel & Kjaer Sound & Vibration Measurement AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Biovica International AB-医療機器分野:企業M&A・提携分析
    Summary Biovica International AB (Biovica) is a biotech company that develops biomarkers for conducting diagnosis and monitoring the cancer patient’s .The company’s DiviTum is a sensitive assay, which is used for measuring activity of thymidine kinase, an enzyme associated with cell proliferation, i …
  • ERG Power Generation SpA:企業の戦略的SWOT分析
    ERG Power Generation SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務分析
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Infratil Ltd (IFT):電力:M&Aディール及び事業提携情報
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • Covance Inc:医療機器:M&Aディール及び事業提携情報
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆